Home

ερωτοτροπώ μετά από αυτό πλήθος ioannis zerdes Εκκεντρικός μπανάνα Εντατικός

Editorial Board | ARC Journal of Cancer Science | High Impact Journals
Editorial Board | ARC Journal of Cancer Science | High Impact Journals

The interplay between eosinophils and T cells in breast cancer  immunotherapy - Zerdes - 2023 - Molecular Oncology - Wiley Online Library
The interplay between eosinophils and T cells in breast cancer immunotherapy - Zerdes - 2023 - Molecular Oncology - Wiley Online Library

Ioannis ZERDES | Postdoctoral Researcher / Resident in Medical Oncology |  MD PhD | Karolinska Institutet, Solna | KI | Department of  Oncology-Pathology | Research profile
Ioannis ZERDES | Postdoctoral Researcher / Resident in Medical Oncology | MD PhD | Karolinska Institutet, Solna | KI | Department of Oncology-Pathology | Research profile

Maria Ekholm och Ioannis Zerdes tilldelas nytt onkologistipendium för  forskning inom bröstcancer
Maria Ekholm och Ioannis Zerdes tilldelas nytt onkologistipendium för forskning inom bröstcancer

Interplay between copy number alterations and immune profiles in the early  breast cancer Scandinavian Breast Group 2004-1 randomized phase II trial:  results from a feasibility study | npj Breast Cancer
Interplay between copy number alterations and immune profiles in the early breast cancer Scandinavian Breast Group 2004-1 randomized phase II trial: results from a feasibility study | npj Breast Cancer

Ioannis Zerdes - Oncology Resident - Karolinska University Hospital |  LinkedIn
Ioannis Zerdes - Oncology Resident - Karolinska University Hospital | LinkedIn

Ioannis Zerdes - Oncology Resident - Karolinska University Hospital |  LinkedIn
Ioannis Zerdes - Oncology Resident - Karolinska University Hospital | LinkedIn

Alexios Matikas on LinkedIn: Ioannis Zerdes får nytt stipendium för sin  bröstcancerforskning | 16 comments
Alexios Matikas on LinkedIn: Ioannis Zerdes får nytt stipendium för sin bröstcancerforskning | 16 comments

Interplay between copy number alterations and immune profiles in the early  breast cancer Scandinavian Breast Group 2004-1 randomized phase II trial:  results from a feasibility study | npj Breast Cancer
Interplay between copy number alterations and immune profiles in the early breast cancer Scandinavian Breast Group 2004-1 randomized phase II trial: results from a feasibility study | npj Breast Cancer

Cancers | Free Full-Text | Beyond PD-1/PD-L1 Inhibition: What the Future  Holds for Breast Cancer Immunotherapy
Cancers | Free Full-Text | Beyond PD-1/PD-L1 Inhibition: What the Future Holds for Breast Cancer Immunotherapy

Ioannis ZERDES | Postdoctoral Researcher / Resident in Medical Oncology |  MD PhD | Karolinska Institutet, Solna | KI | Department of  Oncology-Pathology | Research profile
Ioannis ZERDES | Postdoctoral Researcher / Resident in Medical Oncology | MD PhD | Karolinska Institutet, Solna | KI | Department of Oncology-Pathology | Research profile

Ioannis ZERDES | Postdoctoral Researcher / Resident in Medical Oncology |  MD PhD | Karolinska Institutet, Solna | KI | Department of  Oncology-Pathology | Research profile
Ioannis ZERDES | Postdoctoral Researcher / Resident in Medical Oncology | MD PhD | Karolinska Institutet, Solna | KI | Department of Oncology-Pathology | Research profile

Ioannis Zerdes - Oncology Resident - Karolinska University Hospital |  LinkedIn
Ioannis Zerdes - Oncology Resident - Karolinska University Hospital | LinkedIn

Ioannis Zerdes får nytt stipendium för sin bröstcancerforskning
Ioannis Zerdes får nytt stipendium för sin bröstcancerforskning

Ioannis Zerdes - Oncology Resident - Karolinska University Hospital |  LinkedIn
Ioannis Zerdes - Oncology Resident - Karolinska University Hospital | LinkedIn

Ioannis ZERDES | Postdoctoral Researcher / Resident in Medical Oncology |  MD PhD | Karolinska Institutet, Solna | KI | Department of  Oncology-Pathology | Research profile
Ioannis ZERDES | Postdoctoral Researcher / Resident in Medical Oncology | MD PhD | Karolinska Institutet, Solna | KI | Department of Oncology-Pathology | Research profile

Cancers | Free Full-Text | Discordance of PD-L1 Expression at the Protein  and RNA Levels in Early Breast Cancer
Cancers | Free Full-Text | Discordance of PD-L1 Expression at the Protein and RNA Levels in Early Breast Cancer

Ioannis Zerdes - Civil Engineer - Self-employed engineering, management &  grant consultant. | LinkedIn
Ioannis Zerdes - Civil Engineer - Self-employed engineering, management & grant consultant. | LinkedIn

Maria Ekholm och Ioannis Zerdes tilldelas nytt onkologistipendium för  forskning inom bröstcancer
Maria Ekholm och Ioannis Zerdes tilldelas nytt onkologistipendium för forskning inom bröstcancer

maria ekholm o Ioannis zerdes | Pfizer Sverige
maria ekholm o Ioannis zerdes | Pfizer Sverige

Cancers | Free Full-Text | Discordance of PD-L1 Expression at the Protein  and RNA Levels in Early Breast Cancer
Cancers | Free Full-Text | Discordance of PD-L1 Expression at the Protein and RNA Levels in Early Breast Cancer

Ioannis ZERDES | Postdoctoral Researcher / Resident in Medical Oncology |  MD PhD | Karolinska Institutet, Solna | KI | Department of  Oncology-Pathology | Research profile
Ioannis ZERDES | Postdoctoral Researcher / Resident in Medical Oncology | MD PhD | Karolinska Institutet, Solna | KI | Department of Oncology-Pathology | Research profile

Ioannis ZERDES | Postdoctoral Researcher / Resident in Medical Oncology |  MD PhD | Karolinska Institutet, Solna | KI | Department of  Oncology-Pathology | Research profile
Ioannis ZERDES | Postdoctoral Researcher / Resident in Medical Oncology | MD PhD | Karolinska Institutet, Solna | KI | Department of Oncology-Pathology | Research profile

Ioannis Zerdes m diplom | Pfizer Sverige
Ioannis Zerdes m diplom | Pfizer Sverige

De är först att få nytt stipendium för cancerforskning
De är först att få nytt stipendium för cancerforskning